Information for Health Professionals

ASCIA develops Clinical Updates, Action/Treatment Plans, Guides, Checklists, Position Papers/Statements, Guidelines and e-training courses for health professionals.  

Quick links for this page

Allergic Rhinitis

• ASCIA Clinical Update - Allergic Rhinitis
  
• ASCIA Treatment Plan - Allergic Rhinitis
  
• ASCIA Allergic Rhinitis e-training for health professionals
  
• ASCIA Allergic Rhinitis e-training for pharmacists 
• ASCIA Allergic Rhinitis references Currently being updated
• Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols 
  

Allergy Prevention and Infant Feeding 

• Overview - Infant feeding and allergy prevention
• ASCIA Clinical Update Infant Feeding and Allergy Prevention
• ASCIA Guidelines - Infant feeding and allergy prevention 
• ASCIA Guide: Stepwise management of eczema (atopic dermatitis) management 
• ASCIA Information on how to introduce solid foods to babies for allergy prevention 
  
• ASCIA Guide for introduction of peanut to infants with severe eczema and/or food allergy 
• ASCIA References: Allergy Prevention

Anaphylaxis

• ASCIA Guidelines - Acute management of anaphylaxis Updated July 2020
  
• ASCIA Guidelines - Acute management of anaphylaxis in pregnancy New April 2020
• ASCIA Guidelines - Adrenaline (epinephrine) autoinjector prescription Updated 2020
• ASCIA Guidelines - Prevention of anaphylaxis in schools, pre-schools and childcare: 2015 update
• ASCIA Anaphylaxis Resources Overview   
• ASCIA Checklists - Anaphylaxis New and updated 2020
• ASCIA Event record for allergic reactions Updated 2020
• ASCIA Checklist - Transitioning patients from paediatric to adult services Updated 2020
• ASCIA Checklist - Travel for people with allergy, asthma and anaphylaxis Updated 2020
• ASCIA Anaphylaxis e-training for health professionals Updated 2020
  
• ASCIA Anaphylaxis e-training for pharmacists Updated 2020
• ASCIA Anaphylaxis references Currently being updated

Drug (Medication) Allergy

• Drug (Medication) Allergy Hub
• ASCIA Action Plan for Drug (Medication) Allergy New August 2020
• ASCIA Record for Drug (Medication) Allergy New August 2020
• ASCIA Drug (Medication) Allergy Terms New August 2020
• ASCIA Penicillin Allergy Guide for health professionals Updated August 2020
• ASCIA Consensus Statement - Penicillin Allergy (available to Members only) Updated August 2020
• ASCIA Consensus Statement - Cephalosporin Allergy (available to Members only) Comimg soon
• ASCIA Drug allergy pre-clinic information template (available to Members only)
• ASCIA Clinical Update - Antibiotic Allergy
• ASCIA Penicillin Allergy etraining for health professionals https://etraininghp.ascia.org.au/penicillin-allergy
• ASCIA Drug (Medication) Allergy references Currently being updated

Food Allergy

• ASCIA Guide for Milk Substitutes in Cow’s Milk Allergy New June 2020
• ASCIA Dietary avoidance information sheets 
• ASCIA Information HP - Lupin Allergy
• ASCIA Food Allergy e-training for health professionals 
  
• ASCIA Food Allergy e-training for pharmacists 
  
• ASCIA Food Allergen Challenge Protocols (available to Members only)
• ASCIA Food Allergy references Currently being updated

Immunodeficiency

• Immunodeficiency Overview
  
• ASCIA Immunodeficiency Strategy for Australia and New Zealand Updated October 2020
• Immunodeficiency References Updated October 2020
• Hereditary Angioedema (HAE) References Updated October 2020
• ASCIA Webinar - HAE
  
• ASCIA Position Paper and Management Plan - Hereditary Angioedema (HAE) 
  
• ASCIA Clinical Update - Primary Immunodeficiencies (PID) 
  
• ASCIA Position Statement - Subcutaneous Immunoglobulin (SCIg) 
  
• ASCIA Guide – Setting up a Subcutaneous Immunoglobulin (SCIg) program in a hospital 
• ASCIA Guidelines for Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in Australia and New Zealand: A TAPID Consensus Guideline
• ASCIA Guidelines for standardised IVIg infusion rates for IRT
  
• ASCIA SCIg Treatment Plan 
  
• ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy) 
  
• ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy 
  
• ASCIA ID Register How to access information (available to Members Only)

Immunisation

• ASCIA Guidelines - vaccination of the egg allergic individual 

Insect Allergy      

• ASCIA Guide - Venom Immunotherapy 
• ASCIA Venom and Aeroallergen Immunotherapy templates (available to Members only)
• ASCIA Position Statement - Jack Jumper Ant Venom Immunotherapy
• ASCIA Information for HP - Jack Jumper Ant Allergy - a uniquely Australian problem
• ASCIA Treatment Plan – Subcutaneous Immunotherapy (SCIT) Updated August 2020
• Information about Venom Immunotherapy availability

Latex Allergy

• ASCIA Guidelines - Management of Latex-Allergic Individuals

Skin

• ASCIA Action Plan for Eczema
• ASCIA Guide: Stepwise management of eczema (atopic dermatitis) management 
• ASCIA Paediatric atopic dermatitis (eczema) e-training for health professionals
• ASCIA Guidelines: Chronic Spontaneous Urticaria (CSU)
• ASCIA CSU references Currently being updated

Tests

• ASCIA Food Allergen Challenge Protocols (available to Members only)
• ASCIA Position Statement - Unorthodox Techniques for the Diagnosis and Treatment of Allergy, Asthma and Immune Disorders
• Allergy treatment declared misleading
• Vega Testing in the Diagnosis of Allergic Conditions
  
• ASCIA Skin Prick Testing (SPT) Guide for Health Professionals
• ASCIA Guidelines - Anti-Intrinsic Factor Antibody Testing
• ASCIA Guidelines - Uncertainty of Measurement 
• Laboratory Investigation of Allergic Diseases Updated December 2020
• Unorthodox Testing and Treatment for Allergic Disorders

External Documents

• Australian Airborne Pollen and Spore Monitoring Network Interim Standard and Protocols
• Australian & New Zealand Anaesthetic Allergy Group (ANZAAG) - anaphylaxis management guidelines
• Australian Prescriber Anaphylaxis Wall Chart
• Australian Academy of Science - The science of immunisation
• APIIEG Consensus Recommendations for the Use of Immunoglobulin Replacement Therapy in Immune Deficiency 
• Guidelines for the Use of Infant Formulas to Treat Cows Milk Protein Allergy: an Australian Consensus Panel Opinion
• European Academy of Allergology and Clinical Immunology (EAACI) Testing for IgG4 against Foods is Not Recommended as a Diagnostic Tool 

For information about how ASCIA information is developed go to: www.allergy.org.au/about-ascia/website-information

Content updated December 2020